Stay updated on Pembrolizumab+Bevacizumab+Cyclophosphamide in Recurrent Ovarian Ca Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Bevacizumab+Cyclophosphamide in Recurrent Ovarian Ca Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Bevacizumab+Cyclophosphamide in Recurrent Ovarian Ca Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.0 to v3.6.3, indicating a newer version of the page or template. This change does not alter the study details, eligibility criteria, or outcomes presented on the page.
    Difference
    0.0%
    Check dated 2026-07-05T13:35:37.000Z thumbnail image
  3. Check
    32 days ago
    Change Detected
    Summary
    The page now displays 'No longer looking for participants,' indicating that recruitment for the study has closed.
    Difference
    0.4%
    Check dated 2026-06-14T03:59:34.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    Revision: v3.5.5 replaces v3.5.4, indicating a new page build; the study details remain unchanged.
    Difference
    0.0%
    Check dated 2026-06-06T23:39:15.000Z thumbnail image
  5. Check
    60 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.5.4, replacing the previous v3.5.3, indicating a new build of the page.
    Difference
    0.0%
    Check dated 2026-05-16T09:07:15.000Z thumbnail image
  6. Check
    81 days ago
    Change Detected
    Summary
    The page’s footer version/release label was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” indicating a site software update without changing the clinical trial information displayed.
    Difference
    0.0%
    Check dated 2026-04-25T05:22:12.000Z thumbnail image
  7. Check
    89 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-18T03:48:05.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Bevacizumab+Cyclophosphamide in Recurrent Ovarian Ca Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Bevacizumab+Cyclophosphamide in Recurrent Ovarian Ca Clinical Trial page.